Technetium-99m Radiopharmaceuticals

Saleh, Tamer B.

doi:10.1007/978-3-540-85962-8_3

Cited by 3 publications

(1 citation statement)

References 29 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Its half-life is 6.02 hours and decays via beta decay (with 2% probability) or internal conversion (with 98% probability). The primary gamma emission is a 140 keV photon [15].…”

Section: Introductionmentioning

confidence: 99%

An Investigation to Determine an Optimum Protective Garment Material in Nuclear Medicine

Parvaresh¹,

Haghparast²,

Khoshgard³

et al. 2018

J Biomed Phys Eng

View full text Add to dashboard Cite

Aim: The aim of this study is to find an optimum material to protect garment for protection against 99Tcm radionuclide.Materials and Methods: Monte Carlo simulation code was applied to investigate radiation attenuation of 13 shielding materials including: Ba, gray Sn, white Sn, Sb, Bi, Bi2O3, BaSO4, Sn/W, Sb/W, Pb and W with thicknesses of 0.5 and 1 mm to determine an optimum protective garment material in nuclear medicine against 99Tcm. Furthermore, the dose enhancement on the staff body was investigated for shielding materials such as tungsten and lead.Results: The findings of the simulations show that the maximum and minimum attenuation obtained with thicknesses of 1 mm W and 1 mm BaSO4 were 96.46% and 14.2%, respectively. The results also demonstrate that tungsten does not cause any dose enhancement on staff body but this is not true for lead. Tungsten provides the highest radiation attenuation without dose enhancement on the body of staff.Conclusion: Among materials evaluated, tungsten is the optimum material and it can be applied for the design of protective garment for nuclear medicine staff against 99Tcm.

show abstract

“…Its half-life is 6.02 hours and decays via beta decay (with 2% probability) or internal conversion (with 98% probability). The primary gamma emission is a 140 keV photon [15].…”

Section: Introductionmentioning

confidence: 99%

An Investigation to Determine an Optimum Protective Garment Material in Nuclear Medicine

Parvaresh¹,

Haghparast²,

Khoshgard³

et al. 2018

J Biomed Phys Eng

View full text Add to dashboard Cite

show abstract

Radiolabeled nanomaterials for biomedical applications: radiopharmacy in the era of nanotechnology

Pijeira

Viltres

Kozempel

et al. 2022

EJNMMI radiopharm. chem.

View full text Add to dashboard Cite

Background Recent advances in nanotechnology have offered new hope for cancer detection, prevention, and treatment. Nanomedicine, a term for the application of nanotechnology in medical and health fields, uses nanoparticles for several applications such as imaging, diagnostic, targeted cancer therapy, drug and gene delivery, tissue engineering, and theranostics. Results Here, we overview the current state-of-the-art of radiolabeled nanoparticles for molecular imaging and radionuclide therapy. Nanostructured radiopharmaceuticals of technetium-99m, copper-64, lutetium-177, and radium-223 are discussed within the scope of this review article. Conclusion Nanoradiopharmaceuticals may lead to better development of theranostics inspired by ingenious delivery and imaging systems. Cancer nano-theranostics have the potential to lead the way to more specific and individualized cancer treatment. Graphical abstract

show abstract

Technetium-99m: a Nanomaterial Perspective

Trusova,

Karnaukhov,

Zelinsky

et al. 2024

Ukr. J. Phys.

View full text Add to dashboard Cite

The radiolabeling of nanomaterials with technetium-99m (99mTc) has emerged as a promising strategy for integrating the advantages of nanotechnology and nuclear medicine for both diagnostic and therapeutic applications. This comprehensive review aims to provide an indepth overview of the current state-of-the-art in the radiolabeling of nanomaterials with 99mTc. The exploration encompasses synthesis methods, labeling mechanisms, biological assessments, physicochemical characterizations, and clinical applications of 99mTc-labeled nanomaterials. Diverse categories of nanomaterials are addressed, including organic and inorganic nanoparticles, lipid- and protein-based nanosystems, as well as various carbon nanomaterials. Additionally, the review addresses challenges inherent in this evolving field, such as the stability of the radiolabel, potential nanomaterial toxicity, and regulatory considerations. The discussion is concluded by exploring promising future perspectives and potential areas for research development in the realm of 99mTc-labeled nanomaterials.

show abstract

Technetium-99m Radiopharmaceuticals

Cited by 3 publications

References 29 publications

An Investigation to Determine an Optimum Protective Garment Material in Nuclear Medicine

An Investigation to Determine an Optimum Protective Garment Material in Nuclear Medicine

Radiolabeled nanomaterials for biomedical applications: radiopharmacy in the era of nanotechnology

Technetium-99m: a Nanomaterial Perspective

Contact Info

Product

Resources

About